A trial looking at treatment for myeloma that has come back after a transplant with your own blood stem cells or bone marrow (MMVAR)

Cancer type:

Blood cancers
Myeloma

Status:

Results

Phase:

Phase 2/3

This trial was looking at thalidomide and dexamethasone with or without bortezomib (Velcade) for myeloma that had come back. Everyone in this trial had already had a transplant with their own blood stem cells or bone marrow as treatment for their myeloma. This is known as an autologous transplant.

To have an autologous transplant, you have high dose chemotherapy followed by your own blood stem cells or bone marrow. But sometimes this doesn’t work and the myeloma comes back.

Doctors often use thalidomide and a steroid called dexamethasone to treat myeloma that has come back. Or they may use bortezomib. Bortezomib is a type of biological therapy called a proteasome inhibitor. The researchers want to find out if having all 3 drugs was better than having thalidomide and dexamethasone alone. The aims of this trial were to

  • Find out if it was better to have bortezomib as well as dexamethasone and thalidomide for myeloma that had come back after an autologous transplant
  • Learn more about the side effects of this new combination of treatment

Summary of results

Despite attempting to contact the trial team, we have been unable to get any results for this trial.

Recruitment start:

Recruitment end:

How to join a clinical trial

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Please note - unless we state otherwise in the summary, you need to talk to your doctor about joining a trial.

Chief Investigator

Dr. C. Crawley

Supported by

European Foundation for Blood and Marrow Transplantation (EBMT)

Questions about cancer? Contact our information nurses

Freephone 0808 800 4040

Last review date

CRUK internal database number:

Oracle 2029

Please note - unless we state otherwise in the summary, you need to talk to your doctor about joining a trial.

Over 60,000 cancer patients enrolled on clinical trials in the UK last year.

Last reviewed:

Rate this page:

No votes yet
Thank you!
We've recently made some changes to the site, tell us what you think

Share this page